nach oben

Wiener klinische Wochenschrift

Erschienen in:

01.06.2015 | case report

Unusual treatment of Kasabach–Merritt syndrome secondary to hepatic hemangioma: embolization with bleomycin

verfasst von: Halil Bozkaya, MD, Celal Cinar, MD, Ömer Vedat Ünalp, MD, Mustafa Parildar, MD, Ismail Oran, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 11-12/2015

Einloggen, um Zugang zu erhalten

Summary

Kasabach–Merritt syndrome (KMS) is a rare complication of cavernous hemangiomas characterized with anemia, thrombocytopenia, and consumption coagulopathy. This syndrome usually develops due to superficial soft tissue hemangiomas in infancy and childhood. KMS developing secondarily to hepatic hemangioma is very rare. In this report, we aimed to present the treatment of KMS developing secondarily to giant cavernous hemangioma of the liver with transarterial chemoembolization using bleomycin

Vorheriger Artikel Konsekutive Umstellung auf Tapentadol PR verbessert Analgesie und Lebensqualität bei Patienten mit starken und chronischen Schmerzen unter Tramadol > 300 mg/d

Nächster Artikel Ectopic acromegaly due to a growth hormone-secreting neuroendocrine-differentiated tumor developed from ovarian mature cystic teratoma

Vogel T, Lammers B, von Herbay A, Kunz BM, Donner AJ, Furst G, et al. Kasabach–Merritt syndrome in giant hemangioma of the liver. A case report. Chirurg. 2002;73:729–32.PubMedCrossRef

Hall GW. Kasabach–Merritt syndrome: pathogenesis and management. Br J Haematol. 2001;112:851–62.PubMedCrossRef

Suzuki H, Nimura Y, Kamiya J, Kondo S, Nagino M, Kanai M, et al. Preoperative transcatheter arterial embolization for giant cavernous hemangioma of the liver with consumption coagulopathy. Am J Gastroenterol. 1997;2:688–91.

Althaus S, Ashdown B, Coldwell D, Helton WS, Freeny PC. Transcatheter arterial embolization of two symptomatic giant cavernous hemangiomas of the liver. Cardiovasc Intervent Radiol. 1996;19:364–7.PubMedCrossRef

Ho HY, Wu TH, Yu MC, et al. Surgical management of giant hepatic hemangiomas: complications and review of the literature. Chang Gung Med J. 2012;35(1):70–8.PubMed

Zeng Q, Li Y, Chen Y, Ouyang Y, He X, Zhang H. Gigantic cavernous hemangioma of the liver treated by intraarterial embolization with pingyangmycin–lipiodol emulsion: a multi-center study. Cardiovasc Intervent Radiol. 2004;27(5):481–5.PubMed

Billio A, Pescosta N, Rosanelli C, Zanon GF, Gamba PG, Savastano S, et al. Treatment of Kasabach–Merritt syndrome by embolisation of a giant liver hemangioma. Am J Hematol. 2001;66:140–1.PubMedCrossRef

Malagari K, Alexopoulou E, Dourakis S, Kelekis A, Hatzimichail K, Sissopoulos A, Delis S, Letsou D, Kelekis D. Transarterial embolization of giant liver hemangiomas associated with Kasabach–Merritt syndrome: a case report. Acta Radiol. 2007;48(6):608–12.PubMedCrossRef

Titel: Unusual treatment of Kasabach–Merritt syndrome secondary to hepatic hemangioma: embolization with bleomycin
verfasst von: Halil Bozkaya, MD
Celal Cinar, MD
Ömer Vedat Ünalp, MD
Mustafa Parildar, MD
Ismail Oran, MD
Publikationsdatum: 01.06.2015
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 11-12/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-014-0675-5

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11-12/2015

Delayed auditory pathway maturation and prematurity

Size, edge, and stage of NSCLC determine the release of CYFRA 21-1 in bloodstream

An outbreak of acute gastroenteritis associated with group A Rotavirus in long-term care facility in Slovenia

New educational approach for patients on warfarin improves knowledge and therapy control

mitteilungen der gesellschaft der ärzte in wien

Gregor Gryglewski ist Researcher of the Month Juni 2015